Volcanoes are erupting in The Philippines, but on-fire Australia received some welcome rain. The Iran war cries have been called off and The Donald’s military powers are about to be hamstrung by the Senate. Meanwhile, his impeachment trial is starting, and we’re all on Twitter for a front-row seat.
Tag: Coronavirus
10/08/2021
Vaccines, masks? Japan puzzling over sudden virus success
Almost overnight, Japan has become a stunning, and somewhat mysterious, coronavirus success story.
10/13/2021
Border residents rejoice as US says it will lift travel ban
Beleaguered business owners and families separated by COVID-19 restrictions rejoiced Wednesday after the U.S. said it will reopen its land borders to nonessential travel next month, ending a 19-month freeze.
10/13/2021
Watch: Merck’s Covid pill could transform treatment. Here’s how it works
Earlier this month, study results showed that molnupiravir, Merck’s investigational antiviral pill, cut hospitalization rates of Covid-19 patients by about half.
10/09/2021
Long COVID now has an official WHO clinical definition
The World Health Organisation (WHO) has released an official clinical definition for long covid. The United Nations body released its definition of what it calls "post COVID-19 condition" on Wednesday, flagging that it typically occurs three months from the onset of COVID-19 with symptoms that last for at least two months and "cannot be explained by an alternative diagnosis."
10/06/2021
A Better Way to Think About Your Risk for COVID
For months we’ve been fixated on the idea that some people are at “high risk” and others aren’t. Now scientists have a better understanding of the continuum.
10/06/2021
The White House says it will spend $1 billion to increase the supply of rapid at-home tests.
The White House on Wednesday announced a billion-dollar investment in at-home rapid coronavirus tests that it said would help quadruple their availability by later this year.
10/04/2021
What we know — and don’t know — about Merck’s new Covid-19 pill
The announcement that a pill from Merck and partner Ridgeback Biotherapeutics kept Covid patients out of the hospital made headlines and moved stocks late last week. But as is so often true when data are released by press release, there are still many questions left unanswered.
10/01/2021
Merck says COVID-19 pill cuts risk of death, hospitalization
In a potential leap forward in the global fight against the pandemic, drugmaker Merck said Friday that its experimental pill for people sick with COVID-19 reduced hospitalizations and deaths by half.
09/27/2021
Antibodies in breast milk remain for 10 months after Covid infection – study
Breastfeeding women who have been infected with Covid-19 continue to secrete virus-neutralising antibodies into their milk for up to 10 months, data suggests.
09/24/2021
A daily pill to treat Covid could be just months away, scientists say
At least three promising antivirals that could prevent symptoms and limit transmission of Covid-19 are in clinical trials.
09/21/2021
Six Rules That Will Define Our Second Pandemic Winter
The pandemic keeps changing, but these principles can guide your thinking through the seasons to come.
09/22/2021